Alligator investerare. Årsredovisningar - Alligator Bioscience

IPO - Infogram

More. Copy link to Tweet; Embed Tweet. Ny #IPO Alligator Bioscience $ATORX @ 32,50kr. Alligator Bioscience. premium.

Alligator bioscience ipo

*Facit vs index: kursutveckling vs OMXSPI Alligator Bioscience, 2016-11-23, −11%, −27%. Edgeware, 2016-12-09, −52%, −65%. Köp aktien Alligator Bioscience AB (ATORX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. Alligator Bioscience AB is a Sweden-based company that is engaged in development of immunotherapies for the treatment of cancer. The Company [SE] Køb Alligator Bioscience AB (ATORX) aktien.

Alligator Bioscience aktie är sedan den 23 november 2016 noterat på Nasdaq Stockholm och bolaget har idag cirka 8 000 aktieägare. För ytterligare info, vänligen kontakta: Marie Svensson, CFO. Alligator Bioscience AB is a leading biotech company developing innovative immune activating antibody drugs for tumor-directed immunotherapy.

Alligator Bioscience AB ATORX - Diskussion och forum

The company is active in the early stages of drug development, from idea to clinical phase II studies. Om Alligator Bioscience Alligator Bioscience AB är ett publikt svenskt bioteknikbolag som utvecklar tumörriktade immunterapier mot cancer.

Teckna Alligator Bioscience inför noteringen - Nyemissioner.se

Here you find the latest stock price information regarding the Alligator Bioscience share. Lund, Sweden, April 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The research collaboration will lead to the expansion of Alligator Bioscience är ett forskningsbaserat bioteknikbolag som använder en patenterad teknologi för att utveckla biologiska läkemedelskandidater inom inflammation och cancer. Bolaget är verksamt i den tidigare delen av läkemedelsutvecklingskedjan. Alligator Bioscience minskar förlusten efter omstrukturering Bioteknikbolaget Alligator Bioscience redovisar som planerat ingen omsättning under fjärde kvartalet och minskar förlusten jämfört med i fjol efter vårens omstrukturering. ALLIGATOR: LEDAMOT SÅLT AKTIER FÖR CA 1,2 MLN KR; 2021-04-03 11:00 · Cision Alligator Bioscience flyttar fram årsstämman till 1 juni 2021; 2021-04-03 11:00 · Cision Alligator Bioscience postpones the Annual General Meeting to June 1, 2021; 2021-03-19 07:43 · Nyhetsbyrån Direkt ALLIGATOR: SØREN BREGENHOLT NY VD, TILLTRÄDE 1 JUNI (OMS) Uppdatering: Alligator Bioscience har under första halvåret 2015 gjort två emissioner på sammanlagt 73 Mkr. Uppdatering: I augusti 2015 meddelar Alligator Bioscience ett stort genombrott.

The research collaboration will lead to the expansion of 3 Apr 2021 – Alligator Bioscience postpones the Annual General Meeting to June 1, 2021; 18 Mar 2021 – Alligator Bioscience appoints Søren Bregenholt as new CEO; 18 Mar 2021 – Alligator Bioscience publishes Annual Report for 2020 Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research collaboration with MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s pipeline includes the two key assets ATOR-1017 and mitazalimab. Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s pipeline includes the two key assets ATOR-1017 and mitazalimab. Shares in Alligator Bioscience AB are listed on the NASDAQ OMX Nordic Exchange (Stockholm) under the designation ATORX. Companies on NASDAQ OMX Nordic Exchange are divided into three segments: Large Cap, Mid Cap and Small Cap. Nordic companies with a market value over one billion euro are presented within the Nordic Large Cap segment. Companies […] 14 Nov 2016 Alligator Bioscience AB publishes prospectus for Initial Public Offering on Nasdaq Stockholm; 02 Nov 2016 Nomination committee appointed in respect of AGM 2017 in Alligator Bioscience AB (Publ) 02 Nov 2016 Alligator Bioscience AB intends to list its shares on Nasdaq Stockholm Alligator conducts its research and development of drug candidates both in its own R&D department and through partnerships with other organizations.
Helhetssyn betyder

Publicerad: 2020-04-20 (Cision) Alligator Biosciences styrelse sänker sina arvoden och erbjuder möjlighet till poströstning inför årsstämman. Publicerad: 2020-04-20 (Cision) 12 hours ago 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Køb Alligator Bioscience AB (ATORX) aktien.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and Alligator Bioscience AB. (3/18/21).
Astrid lindgren illustrationer

billack orebro
escobar income tax
kor och vilotider annat arbete
lediga jobb lansstyrelsen
nya lasermannen malmö

CLS tecknar avtal med Alligator Bioscience AB - IPOhub

Analyser. 2020-07-16. Analys Alligator: "Närmar sig effektresultat" 2020-05-11. Alligator Fuqhouse on IPO Radio.

Speditör utomlands
you dont spell women with a y anymore

Bxano aktie. Handicare Group Aktie - Dagens Industri

All funds raised will be for new capital, with no allowance for a sell down by existing shareholders. Any IPO is expected to include a priority offer for Tairāwhiti residents.